Stock Comparison
INCY vs VRTX
Incyte Corporation and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$24.23B
$123.94B
P/E (TTM)
15.2
28.5
Forward P/E
38.4
25.7
Price/Sales
4.2
9.9
Price/Book
3.8
6.1
EV/EBITDA
9.5
23.2
Dividend Yield
—
—
Profitability
Net Margin
26.71%
35.40%
Operating Margin
27.05%
38.97%
Return on Equity
30.70%
23.50%
Return on Assets
16.80%
11.90%
Growth (YoY)
Revenue Growth
37.70%
12.50%
Earnings Growth
37.70%
8.00%
Price & Risk
Beta
0.8
0.3
52-Week High
$129.93
$529.65
52-Week Low
$81.66
$376.62
Analyst Target
$124.96
$559.28
Compare INCY and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.